Rifadin
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II
| Lot or serial number | Brand name | Companies | Dosage form | DIN, NPN, DIN-HIM | Strength |
|---|
| Lot 3099036 | A. Rifadin | - Recalling Firm
- Sanofi Aventis (Canada) Inc.
- 2905 Louis R. Renaud Place
- Laval
- H7V 0A3
- Quebec
- CANADA
- Marketing Authorization Holder
- Sanofi Aventis (Canada) Inc.
- 2905 Louis R. Renaud Place
- Laval
- H7V 0A3
- Quebec
- CANADA
| Capsule | DIN 02091887 | 150 mg / capsule |
Recalled Product
A. Rifadin
Manufacturer testing revealed out-of-specification fill weight results in retention samples for Rifadin 150mg capsules from batch 3099036.
Wholesalers and pharmacies